WallStreetZenWallStreetZen

NASDAQ: ASND
Ascendis Pharma A Stock Ownership - Who owns Ascendis Pharma A?

Insider buying vs selling

Have Ascendis Pharma A insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ASND insiders and whales buy or sell their stock.

ASND Shareholders

What type of owners hold Ascendis Pharma A stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP17.36%10,108,400$1.40BInstitution
Artisan Partners Limited Partnership9.74%5,671,934$783.18MInstitution
Fmr LLC8.48%4,938,461$681.90MInstitution
Westfield Capital Management Co LP7.00%4,075,214$562.71MInstitution
Avoro Capital Advisors LLC6.81%3,966,666$547.72MInstitution
Janus Henderson Group PLC6.47%3,767,203$520.18MInstitution
Wellington Management Group LLP4.72%2,745,872$379.15MInstitution
T Rowe Price Investment Management Inc4.41%2,568,903$354.71MInstitution
Capital International Investors3.76%2,191,312$302.58MInstitution
Franklin Resources Inc3.40%1,981,869$273.66MInstitution

1 of 3

ASND vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ASND100.00%0.00%
ROIV39.48%60.52%Net SellingNet Selling
RVMD89.67%10.33%Net SellingNet Selling
BPMC81.88%18.12%Net SellingNet Selling
CERE26.70%73.30%Net BuyingNet Buying

Ascendis Pharma A Stock Ownership FAQ

Who owns Ascendis Pharma A?

Ascendis Pharma A (NASDAQ: ASND) is owned by 104.20% institutional shareholders, 0.00% Ascendis Pharma A insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual Ascendis Pharma A shareholder, owning 10.11M shares representing 17.36% of the company. Ra Capital Management LP's Ascendis Pharma A shares are currently valued at $1.40B.

If you're new to stock investing, here's how to buy Ascendis Pharma A stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.